Fig. 2From: Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugsMean predicted vs. actual annual all-cause total medical costs and general health score tertile. MS multiple sclerosis*. *All costs adjusted to 2015 US dollars using the medical care component of the Consumer Price IndexBack to article page